| Irfan Galaria, MD, MBA | |
|
24805 Pinebrook Rd Ste 105, Chantilly, VA 20152-4127 | |
| (703) 327-3173 | |
| (703) 327-1743 |
| Full Name | Irfan Galaria |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 23 Years |
| Location | 24805 Pinebrook Rd Ste 105, Chantilly, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1790970556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | 101244923 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Novant Health Uva Health Haymarket Medical Center | Haymarket, VA | Hospital |
| University Of Virginia Medical Center | Charlottesville, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Galaria Plastic Surgery And Dermatology Plc | 7517005515 | 8 |
| Galaria Plastic Surgery And Dermatology Plc | 7517005515 | 8 |
News Archive
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of castration-resistant prostate cancer. ASG-5ME is an antibody-drug conjugate (ADC) targeting the SLC44A4 antigen and is being co-developed by both companies for the treatment of solid tumors.
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).
When a research team asked cocaine addicts to choose, hypothetically, between money now or cocaine of greater value later, "preference was almost exclusively for the money now," said Warren K., Bickel, professor in the Virginia Tech Carilion Research Institute, director of the Advanced Recovery Research Center, and professor of psychology in the College of Science at Virginia Tech.
Researchers from Regenstrief Institute and Indiana University are building and expanding global relationships and collaborations in the fields of public health and health informatics.
Researchers may have found a way to combine imaging with chemotherapy in a single agent for the treatment of prostate cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009
› Verified 2 days ago
| Entity Name | Galaria Plastic Surgery And Dermatology Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881829703 PECOS PAC ID: 7517005515 Enrollment ID: O20091112000053 |
News Archive
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of castration-resistant prostate cancer. ASG-5ME is an antibody-drug conjugate (ADC) targeting the SLC44A4 antigen and is being co-developed by both companies for the treatment of solid tumors.
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).
When a research team asked cocaine addicts to choose, hypothetically, between money now or cocaine of greater value later, "preference was almost exclusively for the money now," said Warren K., Bickel, professor in the Virginia Tech Carilion Research Institute, director of the Advanced Recovery Research Center, and professor of psychology in the College of Science at Virginia Tech.
Researchers from Regenstrief Institute and Indiana University are building and expanding global relationships and collaborations in the fields of public health and health informatics.
Researchers may have found a way to combine imaging with chemotherapy in a single agent for the treatment of prostate cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Irfan Galaria, MD, MBA 24805 Pinebrook Rd, Suite #105, Chantilly, VA 20152-4126 Ph: (703) 327-3173 | Irfan Galaria, MD, MBA 24805 Pinebrook Rd Ste 105, Chantilly, VA 20152-4127 Ph: (703) 327-3173 |
News Archive
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., and Seattle Genetics, Inc. today announced that they have initiated a phase I clinical trial of ASG-5ME for the treatment of castration-resistant prostate cancer. ASG-5ME is an antibody-drug conjugate (ADC) targeting the SLC44A4 antigen and is being co-developed by both companies for the treatment of solid tumors.
The UK will be transformed into a global hub for radiotherapy research, pioneering the use of the latest techniques such as FLASH radiotherapy and artificial intelligence, with a new £56 million research network announced by Cancer Research UK today (Monday).
When a research team asked cocaine addicts to choose, hypothetically, between money now or cocaine of greater value later, "preference was almost exclusively for the money now," said Warren K., Bickel, professor in the Virginia Tech Carilion Research Institute, director of the Advanced Recovery Research Center, and professor of psychology in the College of Science at Virginia Tech.
Researchers from Regenstrief Institute and Indiana University are building and expanding global relationships and collaborations in the fields of public health and health informatics.
Researchers may have found a way to combine imaging with chemotherapy in a single agent for the treatment of prostate cancer, according to data presented at the American Association for Cancer Research 100th Annual Meeting 2009
› Verified 2 days ago